- Home
- ATOS vs EVF Comparison
ATOS vs EVF Comparison
Compare ATOS & EVF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATOS
- EVF
- Stock Information
- Founded
- ATOS 2009
- EVF 1998
- Country
- ATOS United States
- EVF United States
- Employees
- ATOS N/A
- EVF N/A
- Industry
- ATOS Biotechnology: Pharmaceutical Preparations
- EVF Investment Managers
- Sector
- ATOS Health Care
- EVF Finance
- Exchange
- ATOS Nasdaq
- EVF Nasdaq
- Market Cap
- ATOS 96.8M
- EVF 102.2M
- IPO Year
- ATOS 2012
- EVF N/A
- Fundamental
- Price
- ATOS $0.89
- EVF $5.69
- Analyst Decision
- ATOS Strong Buy
- EVF
- Analyst Count
- ATOS 3
- EVF 0
- Target Price
- ATOS $7.13
- EVF N/A
- AVG Volume (30 Days)
- ATOS 611.2K
- EVF 93.3K
- Earning Date
- ATOS 05-13-2025
- EVF 01-01-0001
- Dividend Yield
- ATOS N/A
- EVF 10.68%
- EPS Growth
- ATOS N/A
- EVF N/A
- EPS
- ATOS N/A
- EVF 0.94
- Revenue
- ATOS N/A
- EVF N/A
- Revenue This Year
- ATOS N/A
- EVF N/A
- Revenue Next Year
- ATOS N/A
- EVF N/A
- P/E Ratio
- ATOS N/A
- EVF $6.74
- Revenue Growth
- ATOS N/A
- EVF N/A
- 52 Week Low
- ATOS $0.55
- EVF $5.20
- 52 Week High
- ATOS $1.74
- EVF $6.84
- Technical
- Relative Strength Index (RSI)
- ATOS 64.44
- EVF 54.81
- Support Level
- ATOS $0.78
- EVF $5.60
- Resistance Level
- ATOS $0.92
- EVF $5.73
- Average True Range (ATR)
- ATOS 0.06
- EVF 0.07
- MACD
- ATOS 0.01
- EVF 0.02
- Stochastic Oscillator
- ATOS 81.82
- EVF 86.67
About ATOS Atossa Therapeutics Inc.
Atossa Therapeutics Inc is a clinical stage biopharmaceutical company developing proprietary innovative medicines in areas of unmet medical need in oncology. It focuses on the development of novel therapeutics and delivery methods for the treatment of breast cancer, other breast conditions and COVID-19. The company's drug under development for breast cancer and other breast conditions is Endoxifen. Its two COVID-19 drugs under development are AT-H201, to improve lung function of moderate to severely ill, hospitalized COVID-19 patients by inhalation; and AT-301, a nasal spray for COVID-19 patients for at-home use.
About EVF Eaton Vance Senior Income Trust
Eaton Vance Senior Income Trust is a United States-based diversified, closed-end management investment company. Its investment objective is to provide a high level of current income consistent with the preservation of capital, by investing in senior, secured floating-rate loans. The trust invests in below-investment-grade floating-rate loans, which are considered speculative because of the credit risk of their issuers. Its portfolio of investment consists of aerospace and defense, automotive, beverage, building and development, business equipment and services, cable and satellite television, and other areas.